Treatment Page 3 Posts on Medivizor
Navigation Menu

Treatment Posts on Medivizor

Evaluating Bendamustine-EAM conditioning chemotherapy for patients with mantle cell lymphoma

Posted by on Feb 5, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of bendamustine-EAM (Be-EAM) chemotherapy for patients with mantle cell lymphoma (MCL) before a stem cell transplant. This study found that this regimen improved survival outcomes compared to standard regimens. Some background Stem cell transplants (SCT) remain the standard of care for...

Read More

Is R-CVP safer and more effective than R-CHOP for patients with painless NHL?

Posted by on Feb 5, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of two different chemotherapy regimens for patients with indolent (painless) non-Hodgkin’s lymphoma (NHL). This study found that the R-CVP regimen was similarly effective and had fewer side effects compared to R-CHOP for these patients. Some background Chemoimmunotherapy is the...

Read More

OnabotulinumtoxinA improves symptoms in patients with overactive bladder and urinary incontinence

Posted by on Feb 3, 2020 in Urinary incontinence | 0 comments

In a nutshell This study investigated the effectiveness and safety of onabotulinumtoxinA (OBTA; Botox) in patients with overactive bladder and urinary incontinence. Researchers suggested that OBTA was associated with an improvement in urinary symptoms in these patients. Some background Overactive bladder (OAB) is a chronic disabling condition....

Read More

OnabotulinumtoxinA improves symptoms in patients with overactive bladder and urinary incontinence

Posted by on Feb 3, 2020 in Overactive bladder | 0 comments

In a nutshell This study investigated the effectiveness and safety of onabotulinumtoxinA (OBTA; Botox) in patients with overactive bladder and urinary incontinence. Researchers suggested that OBTA was associated with an improvement in urinary symptoms in these patients. Some background Overactive bladder (OAB) is a chronic disabling condition. The...

Read More

Bevacizumab therapy and surgery are associated with better outcomes in advanced colorectal cancer

Posted by on Jan 31, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether bevacizumab (Avastin) therapy and surgery of the tumor can improve the outcomes of patients with advanced colorectal cancer (CRC). Researchers suggested that patients treated with bevacizumab have better outcomes when undergoing surgery. Some background CRC is one of the most common cancers...

Read More

The sildenafil with L-arginine combined treatment improves the outcomes of patients with erectile dysfunction

Posted by on Jan 31, 2020 in Erectile dysfunction | 0 comments

In a nutshell This study compared the effectiveness and safety of sildenafil (Viagra) with or without L-arginine in patients with erectile dysfunction (ED). Researchers suggested that combining sildenafil and L-arginine results in improved ED outcomes. Some background ED is the inability to get or keep an erection firm enough to have sex. An...

Read More

Can SGLT2 inhibitors help slow down kidney disease in patients with type 2 diabetes?

Posted by on Jan 30, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study investigated whether sodium-glucose cotransporter 2 (SGLT2) inhibitors could help slow down the progression of kidney disease in patients with type 2 diabetes (T2D). This study concluded that SGLT2 inhibitors slowed down kidney function decline compared to other anti-diabetes medications. Some background T2D often leads to...

Read More

Evaluating a combination therapy for the treatment of type 2 diabetes

Posted by on Jan 30, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the safety and effectiveness of a combination treatment between sodium-glucose cotransporter 2 (SGLT) inhibitors and glucagon-like peptide 1 (GLP1) receptor agonists for patients with Type 2 diabetes (T2D). This study concluded that combination treatment improved blood glucose control and reduced weight loss for...

Read More